Biogen
BIIB
#1089
Rank
$18.61 B
Marketcap
$127.04
Share price
0.40%
Change (1 day)
-43.29%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

P/E ratio for Biogen (BIIB)

P/E ratio as of June 2025 (TTM): 12.5

According to Biogen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 12.4897. At the end of 2024 the company had a P/E ratio of 13.6.

P/E ratio history for Biogen from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202413.6-57.71%
202332.2144.26%
202213.2-42.65%
202123.0130.16%
20209.996.16%
20199.41-32.3%
201813.9-47.92%
201726.759.61%
201616.7-16.06%
201519.9-27.01%
201427.3-23.12%
201335.540.52%
201225.317.15%
201121.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Amgen
AMGN
26.3 110.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
22.8 82.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
78.4 527.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
17.2 37.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
16.5 32.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-0.0676-100.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
16.7 33.66%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
-3.04-124.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
-14.9-219.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
109 769.88%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.